Study of Coagulation Activation Markers and Pre Eclampsia
NCT01261351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2014-12-18
Summary
The primary purpose of the trial is to evaluate coagulation activator markers in patients with pre eclampsia compared to control (normal pregnancy) and to correlate these markers with the severity of the pathology.
Conditions
- Pre Eclampsia
Sponsors & Collaborators
-
University Hospital, Lille
lead OTHER
Principal Investigators
-
Véronique Houfflin Debarge, PHD · Universituy Hospital Of Lille, France
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- France
Study Locations
More Related Trials
-
THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin
NCT06575309 ·Status: RECRUITING
-
Micro Array Analysis in Preeclampsia
NCT01914809 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers
NCT01729468 ·Status: COMPLETED ·Phase: PHASE4
-
Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women
NCT04520048 ·Status: RECRUITING ·Phase: NA
-
Thrombophilia Screening After Severe IUGR
NCT05551078 ·Status: UNKNOWN
-
State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays
NCT05625763 ·Status: UNKNOWN
-
Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital
NCT04812821 ·Status: COMPLETED
-
Pregnancy and Risk of Venous Thromboembolism
NCT03659708 ·Status: RECRUITING ·Phase: NA
-
LMWH to Prevent Preeclampsia and Fetal Growth Restriction
NCT00260520 ·Status: TERMINATED
-
Obstetric Antiphospholipid Antibody Syndrome : Contribution of the Evaluation of ADAMTS13 Made at the Diagnosis of Pregnancy on Evaluation the Risk of Pre-eclampsia
NCT04319341 ·Status: COMPLETED
-
Preeclampsia Subtypes and Surrogate Markers of CVD Risk
NCT02337049 ·Status: UNKNOWN
-
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767 ·Status: UNKNOWN
-
Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
NCT03630276 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the LMWH Thromboprophylaxis in Pregnancy
NCT01394107 ·Status: COMPLETED
-
New Biomarkers Associated With the Risk of Premature Delivery.
NCT04067908 ·Status: COMPLETED ·Phase: NA
-
First-trimester Prediction of Preeclampsia
NCT02189148 ·Status: COMPLETED
-
Study of Biological Determinants of Bleeding Postpartum
NCT02884804 ·Status: COMPLETED
-
Prediction of Preeclampsia (PE) at 11-13 Week
NCT03554681 ·Status: COMPLETED
-
Improved Characterisation of Eclampsia
NCT05199558 ·Status: UNKNOWN
-
Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21
NCT01387776 ·Status: TERMINATED
-
Early Placental Insufficiency Screening
NCT01348711 ·Status: TERMINATED
-
Serum Markers in Preeclamptic Women
NCT01361737 ·Status: COMPLETED
-
The Prediction of Preeclampsia/Toxemia in Twin Pregnancy
NCT01255202 ·Status: UNKNOWN
-
Pre-Eclampsia And Growth Restriction: a Longitudinal Study
NCT02379832 ·Status: COMPLETED
-
Safety of Direct Oral Anticoagulant During Pregnancy
NCT06179823 ·Status: COMPLETED